Abstract

New evidence refers to a high degree of heterogeneity in normal but also Alzheimer’s disease (AD) clinical and temporal patterns, increased mortality, and the need to find specific end-of-life prognosticators. This heterogeneity is scarcely explored in very old male AD mice models due to their reduced survival. In the present work, using 915 (432 APP23 and 483 C57BL/6 littermates) mice, we confirmed the better survival curves in male than female APP23 mice and respective wildtypes, providing the chance to characterize behavioral signatures in middle-aged, old, and long-lived male animals. The sensitivity of a battery of seven paradigms for comprehensive screening of motor (activity and gait analysis), neuropsychiatric and cognitive symptoms was analyzed using a cohort of 56 animals, composed of 12-, 18- and 24-month-old male APP23 mice and wildtype littermates. Most variables analyzed detected age-related differences. However, variables related to coping with stress, thigmotaxis, frailty, gait, and poor cognition better discriminated the behavioral phenotype of male APP23 mice through the three old ages compared with controls. Most importantly, non-linear age- and genotype-dependent behavioral signatures were found in long-lived animals, suggesting crosstalk between chronological and biological/behavioral ages useful to study underlying mechanisms and distinct compensations through physiological and AD-associated aging.

Highlights

  • Success in aging and increased life expectancy are historical achievements of the last century

  • Concerning mental health, World Health Organization (WHO)’s last report warns that the prevalence of psychiatric and neurological disorders in older adults, which already account for 6.6% of the total disability-adjusted life years (DALYs), will increase [5]

  • Sex did not influence the risk of mortality in WT littermates, the effect of APP23 genotype in the overall survival was significantly different depending on the sex (S, *** p < 0.001)

Read more

Summary

Introduction

Success in aging and increased life expectancy are historical achievements of the last century. Concerning mental health, World Health Organization (WHO)’s last report warns that the prevalence of psychiatric and neurological disorders in older adults, which already account for 6.6% of the total disability-adjusted life years (DALYs), will increase [5]. Foremost, these disorders are likely to happen in an already complex multimorbid scenario that in most cases will include frailty and age-related medical conditions, strongly affecting the quality of life of Biomedicines 2021, 9, 636. In this worrisome forecast, prevalence and correlates of psychiatric disorders among nursing home residents without dementia are the topic of interest of the systematic review and meta-analysis [6]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call